Reportlinker Adds Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets

NEW YORK, Aug. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets

http://www.reportlinker.com/p0254348/Health-Economics-and-Outcomes-Research-US-Europe-Canada--Emerging-Markets.html

Getting the desired reimbursement can spell the difference between success and failure for a product. Facing narrowing pipelines, life science companies are turning to health economics outcomes research (HEOR) to provide critical evidence-based data for decision — making. HEOR teams juggle multiple demands from and communicate highly technical findings to internal and external clients.

Discover benchmarks unavailable anywhere else. Metrics detail health economics activities, budgets, study costs and return on investment. Data are broken down by company type and geography — find examples applicable to your team. These benchmarks are complemented by experts' insights that will guide team leaders to:

• Define team priorities: Monitor project costs and timelines effectively with benchmarks showing time and money costs for 14 activities. Manage workload by determining what tasks should be outsourced, and use our criteria to select vendors.
• Win organizational buy-in: Learn methods for educating clients on HEOR and for customizing messages. Strengthen coordination with key functions by aligning structure to company goals, assets and future needs. Understand how forward-thinking teams prove their value.
• Hire the right people: Finding candidates who understand economics, science and strategy is rare. See how successful teams find the right talent mix — use our staffing and compensation data to make decisions. Discover how health outcomes liaisons are an integral part of that mix.
• Stay ahead of the curve: Uncover real data as well as best practices from companies leading the way on the latest trends. Investigate risk-sharing agreements, understand comparative effectiveness in the US, and make accessing the emerging markets a reality for your company

KEY METRICS

The five chapters in Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets include benchmarks that detail team structure, staffing, spending, compensation, activities and ROI, as well as costs for individual health economics studies.

Throughout the study, data are broken down by company type — large, mid-sized, or small pharmaceutical firms; medical device firms; and pharmaceutical affiliates. The data are also broken down by geography — United States, Canada and the European Union, and emerging markets.

Chapter 1: Aligning Team Structure and Staffing with Corporate Health Economics Goals

30 data charts focused on the following key points:

Structure and Reporting Lines:

• Specific company example of a centralized market access structure
• Specific company example of a pharmacoeconomics organization
• Major function providing oversight of health economics activities
• Average age of departments
• Level of executive leadership overseeing activities
• Number of groups among which companies split health economics activities

Staffing

• Average health economics team staffing levels
• Health economics team staffing levels by company (United States, EU/ Canada, emerging markets)

Compensation:

• Average total compensation levels by title (management tiers 1 and 2, health economists/analysts and HOLs)

Chapter 2: Health Economics Spending and ROI

46 data charts focused on the following key points:

• Functions contributing to health economics funding
• Percentage of health economics funding contributed by each function
• Number of different functions funding health economics
• Change in health economics spending from 2009 to 2010
• Actual 2009 and projected 2010 health economics spending levels
• Average minimum and maximum per brand health economics expenditures by phase
• Companies' views of the effectiveness of their health economics strategies
• Prevalence of companies that measure ROI on health economics activities

Chapter 3: Team Activities, Budget Breakdowns and Study Costs

77 data charts focused on the following key points:

• Average number of brands a company supports with health economics work
• Phase in which companies begin health economics analysis
• Health economics challenges ranked on a scale of 1 to 10

Activities, Timing Metrics

• Percentage of companies that perform specific health economics activities
• Average percentage of time dedicated to individual health economics activities
• The prototypical health economics team's annual time allocation

Spending Budget Metrics

• Average percentage of budget dedicated to individual health economics activities
• The prototypical health economics team's annual spending allocation

Per Study Costs

• Average price and time necessary to complete the following studies:
• cost-effectiveness analysis
• cost-minimization study
• cost-benefit analysis
• cost-utility analysis
• budget impact model
• comparative effectiveness analysis

Chapter 4: Health Economics Trends and a Look to the Future

21 data charts focused on the following key points:

Health Outcomes Liaisons

• Percentage of companies that employ Health Outcomes Liaisons
• Length of time the health outcomes liaison role has been utilized
• Health outcomes liaison staffing levels
• Regions in which companies currently utilize health outcomes liaisons

Risk-Sharing Agreements:

• Companies' plans to utilize risk-sharing agreements to reach market access goals (current and future)
• Countries in which companies plan to utilize risk-sharing agreements — between now and 2013
• Therapeutic areas that companies believe present the best opportunities for risk-sharing agreements
• Phase when companies begin to investigate risk-sharing agreements

Outsourcing/Vendor Strategy

• Average percentage of health economics studies outsourced
• Vendor strategy — surveyed company example
• Future health economics outsourcing plans
• Therapeutic areas in which companies currently utilize health outcomes liaisons• Future outsourcing plans for companies that currently outsource all health economics work

Chapter 5: Health Economics Team Profiles

Profiles for 11 Health Economics teams: Each company type and geographic region is represented by at least one profile. Each profile contains the following data:

• Background and Structure
• Company Background: Gives benchmarking information to describe the company, including company type, region, age of team and the number of brands supported
• Group Information: An organizational flow chart providing the reporting lines of the health economics group, including team alignment, leadership level and department providing direct oversight of the team
• Outsourcing and Resources Information
• Health Economics Funding by Department: Shows funding allotments by function as well as total team budget
• Staffing and Compensation Information: Lists the positions represented in the health economics team with total FTE counts and compensation levels for each role
• Outsourcing Information: Shows the percentage of the team's spending dedicated to outsourced activities as well as the percentage of health economic studies outsourced to a vendor

Timelines and Study Costs

• Expenditures by Development Phase: Establishes when the team begins working on health economics activities and lists the minimum and maximum expenditures by phase for an average product
• Cost and Time Required to Execute Studies: Gives each
• company's average monetary and time cost necessary to run each of six health economics studies:
• cost-minimization study
• cost-effectiveness analysis
• cost-benefit analysis
• cost-utility analysis
• budget impact model
• comparative effectiveness analysis

Activity Costs

• Percentage of Cost and Time Required to Execute Activities: Provides the percentage of internal time and budget cost devoted to each of the following 11 activities:
• Judging licensing/partnership opportunities
• Supporting pricing decisions
• Preparing content for regulatory submissions
• Developing information for US government payers
• Developing information for private US payers
• Developing information for European government payers
• Developing information for other government payers
• Developing information for non-US private payers
• Valuating products for marketing messages
• Training sales reps and MSLs on pharmacoeconomic data
• Organizing and presenting data for meetings, journals, etc.

Challenges Faced

• Health Economics Challenges: Ranks the team's difficulty in handling several common challenges. Rank is provided on a scale of 1 to 10, with 10 representing the most difficult challenge.

TABLE OF CONTENTS

13 Executive Summary

17 Profiled Companies

18 Study Methodology

19 Study Definitions

21 Health Economics: Five Key Recommendations for Success

30 Aligning Team Structure and Staffing with Corporate Health Economics Goals

33 Health Economics and Outcomes Research Department Structures

54 Team Staffing and Compensation

72 Health Economics Spending and ROI

74 Funding Health Economics through Several Functions

100 Health Economics Spending

117 Proving the Value of Health Economics Analysis to Internal Critics

124 Team Activities, Budget Breakdowns and Study Costs

131 Health Economics Activities by Geography

154 Health Economics Activities by Company Type

182 Per Study Costs and Timelines

208 Health Economics Trends and a Look to the Future

211 Health Outcomes Liaisons

222 Risk-Sharing Agreements

232 Outsourcing

243 Looking to the Future

248 Health Economics Team Profiles

To order this report:

Healthcare Industry: Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets

Healthcare Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker